| Status | 即將出版Forthcoming |
| Study on the compatibility principle of Wutou Decoction based on network pharmacology | |
| Weijie, Wang1,2,3; Xiaonan, Yang1; Yilin, Wang1,4; Hudan, Pan1,5; Liang, Liu1,5 | |
| 2022-03-01 | |
| Source Publication | Digital Chinese Medicine
 |
| ISSN | 2096-479X |
| Volume | 5Issue:1Pages:1-8 |
| Abstract | Objective: To investigate the underlying drug enhancement mechanisms of the Chuanwu (Aconiti Radix) and Huangqi (Astragali Radix) combination and toxicity reduction of Chuanwu combined with Gancao (Glycyrrhizae Radix et Rhizoma) in Wutou Decoction (乌头汤, WTD), and to elucidate the compatibility principle. Methods: The active compounds and potential effective targets of the selected combinations were retrieved from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) and Traditional Chinese Medicines Integrated Database (TCMID). The toxicity of Chuanwu (Aconiti Radix) was investigated by selecting all five toxic compounds from the literature and the TCMSP database, and obtaining their targets through SwissTargetPrediction. Targets related to rheumatoid arthritis (RA) were searched using DisGeNET, GenCards, and Online Mendelian Inheritance in Man (OMIM). Mutual targets between the drug pairs and RA were selected as potential RA therapy targets. The medicinally active compound-target network was constructed using Cytoscape 3.9.0. Gene ontology (GO) term enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment were performed using the Database for Annotation, Visualization, and Integrated Discovery (DAVID) platform. Results: We obtained 191 active compound targets for Gancao (Glycyrrhizae Radix et Rhizoma), 171 for Huangqi (Astragali Radix), and 103 for Chuanwu (Radix Aconiti) (hypoaconitine's target was obtained through literature and SwissTargetPrediction). A total of 5872 genes were obtained for RA. A drug-active compound-target network involving 13 effect-enhancing and nine toxicity reduction targets was constructed. PGR was the main effect enhancement target, and KCNH2 was the main toxicity reduction target. The effect-enhancing targets were related to 23 GO terms (such as positive regulation of transcription from RNA polymerase II promoter, steroid hormone-mediated signaling pathway, plasma membrane, and protein binding) (P < 0.01), and 13 KEGG pathways related to synergism [such as estrogen signaling pathway, cholinergic synapse, and phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) signaling pathway]. The toxicity reduction targets were related to 28 GO terms (mainly involves G-protein coupled receptor signaling pathway, plasma membrane, and drug binding) (P < 0.01), and five KEGG pathways related to toxicity reduction (cholinergic synapse, calcium signaling pathway, regulation of actin cytoskeleton, neuroactive ligand-receptor interaction, and serotonergic synapse). Conclusion: The combination of Chuanwu (Aconiti Radix) and Huangqi (Astragali Radix) plays an important effect-enhancing role in WTD and involves the estrogen and PI3K/Akt signaling pathways, with PGR as the core. The Chuanwu (Aconiti Radix) and Gancao (Glycyrrhizae Radix et Rhizoma) combination decreases toxicity in WTD and is associated with the cholinergic synapse and calcium signaling pathways, with KCNH2 as the core. |
| Keyword | Drug pair Effect enhancement KCNH2 Network pharmacology PGR Toxicity reduction Wutou decoction (乌头汤) |
| DOI | 10.1016/j.dcmed.2022.03.001 |
| URL | View the original |
| Language | 英語English |
| Scopus ID | 2-s2.0-85128118070 |
| Fulltext Access | |
| Citation statistics | |
| Document Type | Journal article |
| Collection | University of Macau |
| Affiliation | 1.Dr. Neher's Biophysics Laboratory for Innovative Drug Discovery/State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macao, 999078, China 2.Rheumatology Department, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310005, China 3.Institue of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, China 4.Famous Doctor Studio, Zhuhai Integrated Traditional Chinese and Western Medicine Hospital, Zhuhai, Guangdong, 519000, China 5.Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou, Guangdong, 510000, China |
| First Author Affilication | University of Macau |
| Recommended Citation GB/T 7714 | Weijie, Wang,Xiaonan, Yang,Yilin, Wang,et al. Study on the compatibility principle of Wutou Decoction based on network pharmacology[J]. Digital Chinese Medicine, 2022, 5(1), 1-8. |
| APA | Weijie, Wang., Xiaonan, Yang., Yilin, Wang., Hudan, Pan., & Liang, Liu (2022). Study on the compatibility principle of Wutou Decoction based on network pharmacology. Digital Chinese Medicine, 5(1), 1-8. |
| MLA | Weijie, Wang,et al."Study on the compatibility principle of Wutou Decoction based on network pharmacology".Digital Chinese Medicine 5.1(2022):1-8. |
| Files in This Item: | There are no files associated with this item. | |||||
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment